Hi boys and girls!
It’s been a while since my last installment of iNews, aka – uh-oh cyber-news, aka – cyber-tales from the dark side, so here’s reviving the series to get back on track in giving you highlights of jaw-dropping cyber-astonishments you might not hear about from your usual sources of news…
In this installment – just one iNews item for you, but it’s plenty: an added item might have watered down the significance of this one (hardly appropriate when there’s ‘watershed’ in the title:)…
Briefly about the iNews: after lengthy legal proceedings in the U.S., a court has ruled in favor of big-pharma company Merck against its insurer for a payout of US$1.4 billion (!!) to cover the damages Merck suffered at the grubby hands of NotPetya (aka ExPetr or simply Petya) in 2017.
Quick rewind back to 2017…
In June of that year, all of a sudden a viciously nasty and technologically advanced encryptor worm – NotPetya – appeared and spread like wildfire. It initially targeted Ukraine, where it attacked victims via popular accounting software – affecting banks, government sites, Kharkov Airport, the monitoring systems of the Chernobyl Nuclear Power Plant (!!!), and so on and so on. Next, the epidemic spread to Russia, and after that – all around the world. Many authoritative sources reckon NotPetya was the most destructive cyberattack ever. Which looks about right when you count the number of attacked companies (dozens of which each lost hundreds of millions of dollars), while overall damage to the world economy was estimated at a minimum 10 billion dollars!
One of the most notable victims of the global cyberattack was the U.S. pharmaceuticals giant Merck. It was reported 15,000 of its computers were zapped within 90 seconds (!) of the start of the infection, while its backup data-center (which was connected to the main network), was lost almost instantly too. By the end of the attack Merck had lost some 30,000 workstations and 7,500 servers. Months went into clearing up after the attack – at a cost of ~1.4 billion dollars, as mentioned. Merck even had to borrow vaccines from outside sources for a sum of $250 million due to the interruptions caused to its manufacturing operations.
Ok, background out the way. Now for the juiciest bit…
Read on…